Literature DB >> 7535765

Truncating alpha-helix E' of p66 human immunodeficiency virus reverse transcriptase modulates RNase H function and impairs DNA strand transfer.

M Ghosh1, K J Howard, C E Cameron, S J Benkovic, S H Hughes, S F Le Grice.   

Abstract

The properties of recombinant p66/p51 human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) containing C-terminal truncations in its p66 polypeptide were evaluated. Deletion end points partly or completely removed alpha-helix E' of the RNase H domain (p66 delta 8/p51 and p66 delta 16/p51, respectively), while mutant p66 delta 23/p51 lacked alpha E' and the beta 5'-alpha E' connecting loop. Although dimerization and DNA polymerase properties of all mutants were not significantly different from those of the parental enzyme, p66 delta 16/p51 and p66 delta 23/p51 RT lacked ribonuclease H (RNase H) activity. In contrast, RT mutant p66 delta 8/p51 retained endonuclease activity but lacked the directional processing feature of the parental enzyme. Despite retaining full endoribonuclease function, p66 delta 8/p51 RT barely supported transfer of nascent (-)-strand DNA between RNA templates representing the 5' and 3' ends of retroviral genome, shedding light on the requirement for the endonuclease and directional processing functions of the RNase H domain during replication.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535765     DOI: 10.1074/jbc.270.13.7068

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  In vitro evidence for the interaction of tRNA(3)(Lys) with U3 during the first strand transfer of HIV-1 reverse transcription.

Authors:  F Brulé; G Bec; G Keith; S F Le Grice; B P Roques; B Ehresmann; C Ehresmann; R Marquet
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Stable complexes formed by HIV-1 reverse transcriptase at distinct positions on the primer-template controlled by binding deoxynucleoside triphosphates or foscarnet.

Authors:  Peter R Meyer; Wiriya Rutvisuttinunt; Suzanne E Matsuura; Antero G So; Walter A Scott
Journal:  J Mol Biol       Date:  2007-03-12       Impact factor: 5.469

3.  Pausing during reverse transcription increases the rate of retroviral recombination.

Authors:  Christian Lanciault; James J Champoux
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  A mutation at position 190 of human immunodeficiency virus type 1 reverse transcriptase interacts with mutations at positions 74 and 75 via the template primer.

Authors:  P L Boyer; H Q Gao; S H Hughes
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

5.  Mutations in HIV reverse transcriptase which alter RNase H activity and decrease strand transfer efficiency are suppressed by HIV nucleocapsid protein.

Authors:  C E Cameron; M Ghosh; S F Le Grice; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

6.  Subunit-specific mutagenesis of the cysteine 280 residue of the reverse transcriptase of human immunodeficiency virus type 1: effects on sensitivity to a specific inhibitor of the RNase H activity.

Authors:  S Loya; H Q Gao; O Avidan; P L Boyer; S H Hughes; A Hizi
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

Review 7.  What is the orientation of DNA polymerases on their templates?

Authors:  S H Hughes; Z Hostomsky; S F Le Grice; K Lentz; E Arnold
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

8.  Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA.

Authors:  S G Sarafianos; K Das; C Tantillo; A D Clark; J Ding; J M Whitcomb; P L Boyer; S H Hughes; E Arnold
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

9.  Mutations in the U5 region adjacent to the primer binding site affect tRNA cleavage by human immunodeficiency virus type 1 reverse transcriptase in vivo.

Authors:  Jangsuk Oh; Mary Jane McWilliams; John G Julias; Stephen H Hughes
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

10.  Characterization of a folding intermediate from HIV-1 ribonuclease H.

Authors:  G Kern; T Handel; S Marqusee
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.